Surgical Wound Infection
Conditions
Keywords
colorectal surgery
Brief summary
This study is a multicenter, open label, observational, postmarketing surveillance study of the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to investigate specific aspects of infection rates and hospital length of stay following routine use of this device in patients undergoing colorectal surgical procedures.
Detailed description
This study is a multicenter, open label, observational, postmarketing surveillance study of the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to investigate specific aspects of infection rates and hospital length of stay following routine use of this device in patients undergoing colorectal procedures.
Interventions
Continuous infusion of local anesthetic to surgical site
IV opioids delivered via PCA
Sponsors
Study design
Eligibility
Inclusion criteria
* Men and women, \>18 years of age; * Scheduled for elective colon procedure; * Ability to complete patient survey questionnaires; * Provision of informed consent
Exclusion criteria
* Patients with a prior allergic reaction to Morphine, Demerol, Dilaudid, Fentanyl, Marcaine (bupivacaine), lidocaine or Naropin (ropivacaine); * Procedures for hemorrhoids; * Inability to perform follow up assessments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical site infection | 30 days postoperative |
Secondary
| Measure | Time frame |
|---|---|
| Hospital length of stay | Average 1 week |